Antisense Therapeutics Limited (AU:PER) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics Limited has requested a trading halt on its securities pending a significant announcement related to a capital raising. This pause in trading aims to ensure the capital raising process is conducted smoothly and is expected to be lifted once the announcement is made or by the start of trading on October 18, 2024.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.